Study Setting and Participants
Study design
This is a pre- and post-test randomized controlled study and included three parallel groups, VRG, TT and control. A single-blind, parallel group randomized controlled trial was used to evaluate the effect of using VRG and TT on pain, anxiety and patient satisfaction in women during the intrauterine insemination procedure. This clinical trial is registered at ClinicalTrials.gov (ref. no: xxxxxxxx). Reporting adhered to the CONSORT extension for parallel group randomized trials (Sunay et al., 2013; CONSORT 2010 Flow Diagram, accessed on 16 April 2019) and the TIDieR checklist (The CONSORT 2010 Checklist, accessed on 4 April 2023).
Study Setting and Participants
We conducted the study in a infertility polyclinic of a provincial education and trainig hospital in the northern Region,in Türkiye. Prior to the study, women presented to the outpatient clinic for the iui procedure were told about the free iui procedure and they were invited to participate in the study.
Volunteering women who were attending the IUI between January and June 2022 and satisfying the inclusion criteria were recruited.
At the infertility clinic where the study was conducted, IUI is carried out by appointment every day during the working week. On the days that IUI was carried out during the study, the researchers evaluated the suitability of women who had IUI appointments for the study. The women who underwent IUI procedures rested for 15 minutes without getting up following the treatment, which took an average of 15 minutes. There were two experimental groups and one control group. One experimental group was the VRG application group and the other was the TT group. The control group received no intervention apart from routine care at the infertility center. The nurses did not apply any non-pharmacological pain management measures during the procedure. This was one of the main reasons for choosing this hospital and center.
Inclusion criteria
Over the age of 18, at least primary school graduate, without a diagnosed psychiatric disease, Women who do not have mental disability and communication problems, who do not have drug sensitivity and allergy, constitute the criteria for participation in the research.
Exclusion criteria
Women who were illiterate, had a diagnosed psychiatric illness, had mental disability and communication problems, were younger than 18 years old, did not volunteer to participate in the study, and had drug sensitivity and allergies were not included in the study.
Sample Size
The study sample consisted of women who met the inclusion criteria. To calculate the sample size of the study, a power analysis was performed using the G*Power program 3.1.9 based on the pain level data in a similar study (19). In this analysis, it was determined that at least 32 participants in each group should be included, with a 95% confidence level (1-α), 55% test strength (1-β), and effect size of d = 0.6875.
Randomization
No stratified distinction was made because all participants were of the same gender and all were in reproductive age. No stratification was made for any factor. Blocking (6-cell and 4-cell blocks) was performed only for randomization. The blocks were then randomly assigned to VRG, TT and control groups using a random numbers table generated by a statistical expert on the computer. In order to prevent bias and ensure confidentiality during randomization, it was performed by a statistical expert not from among the authors. A total of 96 women, 32 women in each group (VRG,TT and control), were randomly selected according to the sample size determined by the effect width. Thirty three women were included in the VR group, 32 women were TT group and 32 women in the control group. Pre-test and post-test data were collected and transferred to the computer by a graduate student blinded to group allocations. The analysis of the data coded in terms of groups was done by a statistical expert. After statistical analyses were completed and the research report was written, the researcher explained the coding for the VRG, TT and control groups. In this way, single blinding was applied to the researcher. 110 women were assessed for eligibility, 14 of them were excluded. A total of 96 women were randomized to VRG group (n = 32), TT group (n = 32) and control group (n = 32)(Fig. 1).
Data collection
Data were collected from January and June 2022. Four forms were used to collect the data and the data were collected in two phases.
Phase 1 (pre-test): In both VRG, TT and control groups, Demographic and VAS for pain Form, Spielberg State-Trait Anxiety Inventory (STAI), were administered.
Phase 2(post test): In both VRG, TT and control groups, after iui procedure. Demographic and VAS for pain Form, Spielberg State-Trait Anxiety Inventory (STAI), Visual Analog Scale for Satisfaction(VAS-satisfaction) were administered.
Measurement Tools
Visual Analog Scale for Pain
The scale, developed by Hayes and Patterson in 1921, is a one-dimensional, 0–10 cm (0-100 mm) measuring instrument commonly used to measure severity of pain. This measurement tool can be used horizontally or vertically. The scale starts with "no pain" and ends with "unbearable pain." High scores on the scale indicate a high severity of pain. The cutoff points for the scores obtained on the scale are 0 cm "no pain," 1–4 cm "mild pain," 5–6 cm "moderate pain," and 7–10 cm "severe pain" (21).Visual Analogue Scale [VAS] at baseline before treatment, while treatment and 15 second after treatment.
Visual Analog Scale for Satisfaction(VAS-satisfaction)
Satisfaction level was measured using the visual analog scale. VAS is used to convert some numerically unmeasured values to numeric values. VAS is a continuous scale tahat comprises a horizontal line or a vertical line,usually 10 cm in a length. ‘I am not satisfied at all’(zero point), whereas the statement at the other end is ‘very satisfied’. Patients were asked to mark their satisfactin levels on this scale of 10 cm. Satisfaction were evaluated using the Visual Analogue Scale [VAS] 15 second after treatment.
Spielberg State-Trait Anxiety Inventory (STAI)
This inventory consists of two separate self-report scales, the State Anxiety Inventory and the Trait Anxiety Inventory, each comprising 20 items and structured according as a four-point Likert-type scale. The State Anxiety Inventory refers to how the person feels at a specific time and under specific conditions, and is answered with one of the statements 1(“…”), 2 (“a little”), 3 (“a lot”), 4 (“completely”) depending on the severity of the feelings at that time. The Trait Anxiety Inventory refers to how the person usually feels and is answered with one of the statements 1 (“almost never”), 2 (“sometimes”), 3 (“most of the time”), 4 (“always”) depending on the severity of the constant feelings. The scores obtainable from both scales ranges from 20 to 80, and an increase in the overall score corresponds to an increase in the amount of anxiety. In the Turkish adaptation of the inventory, the Cronbach's alpha reliability coefficients were found to range from 0.83 to 0.92 for the State Anxiety Inventory and from 0.83 to 0.87 for the Trait Anxiety Inventory(22). Anxiety was evaluated using the State Anxiety Inventory at baseline before treatment and 15 second after treatment.
Intervention
At the infertility clinic where the study was conducted, the IUI technique is carried out by appointment every day during the working week. The researchers evaluated the eligibility to participate in the study of the women who had IUI appointments on the days when IUI applications were being accepted. The women who underwent IUI procedures rested for 15 minutes without getting up following the treatment, which took an average of 15 minutes. There were two experimental groups and one control group. One of the experimental groups was the VRG application group and the other was the TT group. The control group received no intervention apart from routine care at the infertility center.
VRG Intervention
VRG are devices that work with compatible smartphones. They can be used to view videos taken at a 360-degree angle, and any type of wired headphones can be connected to the audio output. Viewing relaxing images accompanied by relaxing music with VRG during the invasive procedure allows the women to embark on an imaginary journey that takes them away from the clinic in which they are surrounded by medical equipment and leads them into a more tranquil environment. The use of VRG is thought to increase the release of endorphins and oxytocin hormones while decreasing adrenaline levels, resulting in physical relaxation. The technology can be used for pain relief as a non-invasive, effective pain-relieving method. This approach was chosen because studies utilizing VRG have demonstrated that it is an efficient way to manage pain (7, 8, 23–25). A video showing a natural setting and music featuring nature sounds was shown to the women in the VRG application group for a total of 30 minutes, 15 minutes prior to and 15 minutes following the IUI process. The goggles' headphones were used to listen to a music recording that featured natural noises. The VRG were given to the women before the procedure. The glasses were put on before the procedure began and were not removed during the procedure. The goal was to enable the women to observe nature more effectively and listen to its sounds, allowing them to focus on the images and sounds and distract themselves from the tension of the current environment. Each woman was shown the same video and the glasses were disinfected after each use.
Therapeutic Touch Intervention
The women in the TT group received a total of 30 minutes of TT only, 15 minutes before the IUI treatment and for 15 minutes during the IUI treatment.
The participants and researchers were not blinded due to the nature of the study. To prevent the possibility of meeting, sharing experiences, and interaction between women in the groups, the participants were taken alone to an isolated room right next to the IUI room and administered TT or VRG before being taken to the IUI room for the procedure. After the procedure, the final tests were performed in another room by another researcher. To avoid statistical bias, the experimental and control groups were assigned the codes x, y, and z, and the groups were hidden from the statistician during data analysis when the data were transferred to the SPSS program. There was no interference with the routine procedures and care of the women during the study.
Data analysis
Data were presented with descriptive statistics such as number, percentage, arithmetic mean, standard deviation. Mann Whitney-U test was used for categorical variables, and Kruskal Wallis-H analysis for the continuous variables to confirm differences in sociodemographic characteristics and some outcomes of health and IUI between the groups. The scores of the VAS (for pain) and STAI between groups were compared Kruskal Wallis H analysis, Tukey test and for comparison within groups was used Freidman Test and Wilcoxon Test. Statistical significance value was accepted as p < 0.05.